Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

TDNA vs. CIBR: which is better?

Bottom line

TDNA vs CIBR: the short answer

TDNA (T. Rowe Price Biotech ETF) and CIBR (First Trust NASDAQ Cybersecurity ETF) are both etfs.

Updated Nov 19, 2026

TDNA vs CIBR side by side

TDNACIBR
TypeETFETF
Fund familyT. Rowe PriceFirst Trust
CategoryTechnology SectorTechnology Sector
Expense ratio—0.58%
Annual cost per $10k—$58
10-yr cost on $10k (prospectus)——
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+13.1%
5-yr return (annualized)—+10.5%
10-yr return (annualized)—+15.6%
Best quarter—+28.7%
Worst quarter—−23.9%
Net assets (fund)—$13.8B
Number of holdings—44
Portfolio turnover—21%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

TDNA and CIBR share none of their top holdings.

TDNA top 10

    CIBR top 10

    1. Palo Alto Networks Inc — 9.62%
    2. Fortinet Inc — 8.85%
    3. Crowdstrike Holdings Inc — 8.29%
    4. Cisco Systems Inc — 7.75%
    5. Broadcom Inc — 6.72%
    6. Cloudflare Inc — 4.03%
    7. Okta Inc — 3.52%
    8. F5 Inc — 3.41%
    9. Zscaler Inc — 3.04%
    10. Akamai Technologies Inc — 2.84%

    FAQ

    What is the difference between TDNA and CIBR?
    TDNA (T. Rowe Price Biotech ETF) and CIBR (First Trust NASDAQ Cybersecurity ETF) are both etfs.
    Should I own both TDNA and CIBR?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.